Augmented ST-segment elevation during recovery from exercise predicts cardiac events in patients with Brugada syndrome.

OBJECTIVES The goal of this study was to evaluate the prevalence and the clinical significance of ST-segment elevation during recovery from exercise testing. BACKGROUND During recovery from exercise testing, ST-segment elevation is reported in some patients with Brugada syndrome (BrS). METHODS Treadmill exercise testing was conducted for 93 patients (91 men), 46 ± 14 years of age, with BrS (22 documented ventricular fibrillation, 35 syncope alone, and 36 asymptomatic); and for 102 healthy control subjects (97 men), 46 ± 17 years of age. Patients were routinely followed up. The clinical end point was defined as the occurrence of sudden cardiac death, ventricular fibrillation, or sustained ventricular tachyarrhythmia. RESULTS Augmentation of ST-segment elevation ≥0.05 mV in V(1) to V(3) leads compared with baseline was observed at early recovery (1 to 4 min at recovery) in 34 BrS patients (37% [group 1]), but was not observed in the remaining 59 BrS patients (63% [group 2]) or in the 102 control subjects. During 76 ± 38 months of follow-up, ventricular fibrillation occurred more frequently in group 1 (15 of 34, 44%) than in group 2 (10 of 59, 17%; p = 0.004). Multivariate Cox regression analysis showed that in addition to previous episodes of ventricular fibrillation (p = 0.005), augmentation of ST-segment elevation at early recovery was a significant and independent predictor for cardiac events (p = 0.007), especially among patients with history of syncope alone (6 of 12 [50%] in group 1 vs. 3 of 23 [13%] in group 2) and among asymptomatic patients (3 of 15 [20%] in group 1 vs. 0 of 21 [0%] in group 2). CONCLUSIONS Augmentation of ST-segment elevation during recovery from exercise testing was specific in patients with BrS, and can be a predictor of poor prognosis, especially for patients with syncope alone and for asymptomatic patients.

[1]  P. C. Viswanathan,et al.  Two distinct congenital arrhythmias evoked by a multidysfunctional Na(+) channel. , 2000, Circulation research.

[2]  W. Shimizu,et al.  Mechanisms of Disease: current understanding and future challenges in Brugada syndrome , 2005, Nature Clinical Practice Cardiovascular Medicine.

[3]  Wataru Shimizu,et al.  Brugada syndrome: report of the second consensus conference. , 2005, Heart rhythm.

[4]  S. Sharma,et al.  Unmasking of the Brugada phenotype during exercise testing and its association with ventricular arrhythmia on the recovery phase , 2009, Heart.

[5]  N. Hagiwara,et al.  Long-Term Prognosis of Probands With Brugada-Pattern ST-Elevation in Leads V1–V3 , 2009, Circulation. Arrhythmia and electrophysiology.

[6]  M. Hori,et al.  Vagally mediated heart rate recovery after exercise is accelerated in athletes but blunted in patients with chronic heart failure. , 1994, Journal of the American College of Cardiology.

[7]  J. Goldberger,et al.  Assessment of autonomic function in cardiovascular disease: physiological basis and prognostic implications. , 2008, Journal of the American College of Cardiology.

[8]  J. Brugada,et al.  Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. , 1992, Journal of the American College of Cardiology.

[9]  M Borggrefe,et al.  Long-Term Prognosis of Patients Diagnosed With Brugada Syndrome: Results From the FINGER Brugada Syndrome Registry , 2010, Circulation.

[10]  J. Brugada,et al.  Natural History of Brugada Syndrome: , 2003, Journal of cardiovascular electrophysiology.

[11]  G. Breithardt,et al.  Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients. , 2002, Journal of the American College of Cardiology.

[12]  W. Shimizu,et al.  ST-segment elevation and ventricular fibrillation without coronary spasm by intracoronary injection of acetylcholine and/or ergonovine maleate in patients with Brugada syndrome. , 2002, Journal of the American College of Cardiology.

[13]  C Antzelevitch,et al.  Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent. , 1999, Circulation research.

[14]  J. Saul,et al.  Modulation of cardiac autonomic activity during and immediately after exercise. , 1989, The American journal of physiology.

[15]  N. Hagiwara,et al.  Long-Term Prognosis of Probands With Brugada-Pattern ST-Elevation in Leads V 1 – V 3 , 2009 .

[16]  W. Haskell,et al.  Autonomic contribution to heart rate recovery from exercise in humans. , 1982, Journal of applied physiology: respiratory, environmental and exercise physiology.

[17]  Colleen E. Clancy,et al.  Na+ Channel Mutation That Causes Both Brugada and Long-QT Syndrome Phenotypes: A Simulation Study of Mechanism , 2002, Circulation.

[18]  Lars Eckardt,et al.  Role of programmed ventricular stimulation in patients with Brugada syndrome: a meta-analysis of worldwide published data. , 2007, European heart journal.

[19]  G. Breithardt,et al.  Long-Term Prognosis of Individuals With Right Precordial ST-Segment–Elevation Brugada Syndrome , 2005, Circulation.

[20]  C. Antzelevitch,et al.  Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. , 1999, Circulation.

[21]  C Antzelevitch,et al.  Differences in the electrophysiological response of canine ventricular subendocardium and subepicardium to acetylcholine and isoproterenol. A direct effect of acetylcholine in ventricular myocardium. , 1990, Circulation research.

[22]  J. Ruijter,et al.  Exercise-Induced ECG Changes in Brugada Syndrome , 2009, Circulation. Arrhythmia and electrophysiology.

[23]  R. Brugada,et al.  Functional expression of "cardiac-type" Nav1.5 sodium channel in canine intracardiac ganglia. , 2006, Heart rhythm.

[24]  M. O'Neill,et al.  Outcome After Implantation of a Cardioverter-Defibrillator in Patients With Brugada Syndrome: A Multicenter Study , 2006, Circulation.

[25]  T. Ikeda,et al.  Noninvasive Risk Stratification of Subjects with a Brugada‐Type Electrocardiogram and No History of Cardiac Arrest , 2005, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

[26]  Harlan M Krumholz,et al.  ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker , 2008, Journal of the American College of Cardiology.

[27]  Y. Aizawa,et al.  Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. , 1996, Journal of the American College of Cardiology.

[28]  Long-Term Follow-Up of Individuals With the Electrocardiographic Pattern of Right Bundle-Branch Block and ST-Segment Elevation in Precordial Leads V1 to V3 , 2002 .

[29]  A. Wilde,et al.  Delay in Right Ventricular Activation Contributes to Brugada Syndrome , 2004, Circulation.

[30]  S. Priori,et al.  Natural History of Brugada Syndrome: Insights for Risk Stratification and Management , 2002, Circulation.

[31]  W. Shimizu,et al.  Neurally Mediated Syncope as a Cause of Syncope in Patients with Brugada Electrocardiogram , 2010, Journal of cardiovascular electrophysiology.

[32]  T. Ikeda,et al.  The Full Stomach Test as a Novel Diagnostic Technique for Identifying Patients at Risk of Brugada Syndrome , 2006, Journal of cardiovascular electrophysiology.

[33]  J. Towbin,et al.  Long-Term Follow-Up of Individuals With the Electrocardiographic Pattern of Right Bundle-Branch Block and ST-Segment Elevation in Precordial Leads V 1 to V 3 , 2001 .